β-淀粉样蛋白与血管风险对纵向脑萎缩模式的关联
在196名临床正常老年人中,较高血管风险与较高β-淀粉样蛋白负荷交互预测额颞叶、丘脑和纹状体更严重萎缩;较高β-淀粉样蛋白负荷而非血管风险与顶枕叶和海马更严重萎缩相关;灰质萎缩介导了高β-淀粉样蛋白负荷下血管风险与认知下降的关联。
要点
- 血管风险与β-淀粉样蛋白负荷交互预测额颞叶、丘脑和纹状体纵向萎缩。
- 较高β-淀粉样蛋白负荷而非血管风险与顶枕叶和海马萎缩相关。
- 灰质萎缩介导高β-淀粉样蛋白负荷下血管风险与认知下降的关联。
核心结论
- 观察到较高血管风险与较高β-淀粉样蛋白负荷的交互作用与纵向脑萎缩相关,进而影响认知下降。
- 这些结果支持将血管风险管理作为延缓临床前阿尔茨海默病神经变性和认知下降的潜在干预措施。
研究设计与样本
- 研究纳入哈佛衰老脑研究的196名临床正常成人,年龄73.8±6.1岁。
- 基线β-淀粉样蛋白负荷用匹兹堡化合物B PET定量,基线血管风险用弗雷明汉心脏研究心血管疾病风险评分测量。
- 脑萎缩用结构MRI纵向定量,中位随访4.50±1.26年;认知每年用临床前阿尔茨海默认知复合量表评估,中位随访6.25±1.40年。
- 采用线性混合效应模型检验血管风险和β-淀粉样蛋白负荷作为交互 versus 独立预测因子,并调整年龄、性别、受教育年限、APOE ε4状态、颅内体积(适当时)及其与时间的交互。
- 后续模型调整白质损伤标志物以确定血管风险是否独立于扩散和FLAIR标志物加速脑萎缩;中介分析检验脑萎缩是否介导血管风险和β-淀粉样蛋白负荷对认知下降的交互关联。
主要发现
- 较高血管风险和较高β-淀粉样蛋白负荷交互预测额叶、颞叶、丘脑和纹状体更严重萎缩。
- 较高β-淀粉样蛋白负荷而非血管风险与顶叶、枕叶及海马更严重萎缩相关。
- 调整基于扩散和FLAIR的白质损伤标志物对上述关联影响很小。
- 灰质萎缩介导了较高β-淀粉样蛋白负荷水平下血管风险与认知下降的关联。
临床怎么用
- 作者认为这些结果支持将血管风险管理作为延缓临床前阿尔茨海默病神经变性和认知下降的潜在干预措施。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Vascular risk factors and elevated β-amyloid (Aβ) are commonly observed together among older adults. Here, we examined the interactive vs independent effects of systemic vascular risk and Aβ burden on longitudinal gray matter atrophy and how their co-occurrence may be related to cognitive decline in a cohort of clinically normal adults. A secondary goal was to examine whether vascular risk influences gray matter atrophy independently from markers of white matter injury. METHODS: Participants were 196 adults (age 73.8 ± 6.1 years) from the Harvard Aging Brain Study. Baseline Aβ burden was quantified with Pittsburgh compound B PET. Baseline vascular risk was measured with the Framingham Heart Study cardiovascular disease risk score. Brain atrophy was quantified longitudinally with structural MRI over a median of 4.50 (±1.26) years. Cognition was assessed yearly with the Preclinical Alzheimer Cognitive Composite over a median of 6.25 (±1.40) years. Linear mixed-effects models examined vascular risk and Aβ burden as interactive vs independent predictors of gray matter atrophy, with adjustment for age, sex, years of education, APOE ε4 status, intracranial volume (when appropriate), and their interactions with time. In subsequent models, we adjusted for markers of white matter injury to determine whether vascular risk accelerated brain atrophy independently from diffusion- and fluid-attenuated inversion recovery (FLAIR)-based markers. Mediation analyses examined whether brain atrophy mediated the interactive association of vascular risk and Aβ burden on cognitive decline. RESULTS: Higher vascular risk and elevated Aβ burden interacted to predict more severe atrophy in frontal and temporal lobes, thalamus, and striatum. Higher Aβ burden, but not vascular risk, was associated with more severe atrophy in parietal and occipital lobes, as well as the hippocampus. Adjusting for diffusion- and FLAIR-based markers of white matter injury had little impact on the above associations. Gray matter atrophy mediated the association between vascular risk and cognitive decline at higher levels of Aβ burden. DISCUSSION: We observed an interaction between elevated vascular risk and higher Aβ burden with longitudinal brain atrophy, which in turn influenced cognitive decline. These results support vascular risk factor management as a potential intervention to slow neurodegeneration and cognitive decline in preclinical Alzheimer disease.
引用
- Rabin JS, Pruzin J, Scott M, et al. Association of β-Amyloid and Vascular Risk on Longitudinal Patterns of Brain Atrophy. Neurology. 2022. PMID: 35473760. doi:10.1212/WNL.0000000000200551
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。